ArticleFrontiers in pharmacology2022

COMMD4 is a novel prognostic biomarker and relates to potential drug resistance mechanism in glioma.

Zongheng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.